Eventide Asset Management’s Avidity Biosciences RNAM Stock Holding History

Eventide Asset Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-524,643	Closed	-$37.8M	–	302
2025 Q4	$37.8M	Buy	524,643 +148,654	+40%	+$9.6M	0.59%	59
2025 Q3	$16.4M	Buy	375,989 +65	+0%	+$2.63K	0.27%	110
2025 Q2	$10.7M	Hold	375,924	–	–	0.19%	123
2025 Q1	$11.1M	Hold	375,924	–	–	0.22%	121
2024 Q4	$10.9M	Hold	375,924	–	–	0.2%	130
2024 Q3	$17.3M	Hold	375,924	–	–	0.3%	98
2024 Q2	$15.4M	Buy	+375,924	New	+$10.8M	0.26%	106

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Eventide Asset Management's RNAM Position: Q1 2026 in Review

Eventide Asset Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 524,643 shares — an estimated $37.8M sold.

Eventide Asset Management first reported a position in RNAM in Q2 2024 and held it in 7 quarters. The position peaked at $37.8M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Eventide Asset Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Eventide Asset Management sold 524,643 Avidity Biosciences shares in Q1 2026, an estimated $37.8M.
Eventide Asset Management first reported a position in Avidity Biosciences in Q2 2024 and held it in 7 quarters.
Eventide Asset Management's Avidity Biosciences position peaked at $37.8M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Eventide Asset Management's 13F filing for Q1 2026, filed 15 May 2026.